ask="3.31"
ask_size="4000"
average_daily_volume="169597"
bid="1.49"
bid_size="2500"
book_value="0.39"
change="+0.02"
change_from_200_day_moving_average="-0.05"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-0.45"
change_From_52_week_low="0.73"
change_in_percent="+1.32%"
close="1.53"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35270000"
high="1.53"
high_52_weeks="1.98"
last_trade_date="2/17/2017"
last_trade_price="1.53"
last_trade_size="282"
last_trade_time="4:00pm"
low="1.50"
low_52_weeks="0.80"
market_capitalization="103.37M"
moving_average_200_day="1.58"
moving_average_50_day="1.55"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.51"
pe_ratio="N/A"
peg_ratio="-0.54"
percent_change_from_200_day_moving_average="-3.43%"
percent_change_from_50_day_moving_average="-1.42%"
percent_change_from_52_week_high="-22.73%"
percent_change_from_52_week_low="+91.25%"
previous_close="1.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.91"
price_per_sales="1.95"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="7.30"
stock_exchange="NCM"
symbol="BIOL"
volume="74390"
weeks_range_52="0.80 - 1.98"
